This year, thousands of MEN - C&EN Global Enterprise (ACS

Nov 16, 2010 - Advertisements that appeared within the print issues of Chem. Eng. News have been included in the C&EN Archives to provide a ...
1 downloads 0 Views 348KB Size
This year,

thousands J will find out they have

specializing in anti-cancer bulk active manufacturing not just because we can...

should.

Companies like yours around the world are engaged in the batde against cancer. ChemSyn is proud to assist in this fight. With years of experience in anti-cancer bulk active manufacturing, we've helped many pharmaceutical companies in their efforts to develop new, more effective cancer-fighting drugs. We provide a wide range of services to our customers including process development and scale-up, process validation, custom radiosynthesis and bulk manufacturing under cGMP To meet the growing number of new anti-cancer drugs in

development, we are expanding our capability to manufacture cytotoxic and other highly potent compounds. Specialized containment facilities and isolation suites are under construction at our FDA inspected and approved facilities. Sure, we do what we do because it makes our business successful. But, really, knowing that the work we do may help save lives and keep families together gives us all the L A B O R A T O R I E S incentive we'll ever need.

1(800)233-6643 · www.chemsyn.com · Fax 1 (913) 888-3582 CIRCLE 8 ON READER SERVICE CARD

ChemSyn A member

of the Technologies

Division,

Cagle-Picher

Industries,

Inc.